USE OF SOMATOSTATIN ANALOGS IN CONTROL OF HYPOGLYCEMIA
First Claim
Patent Images
1. A method of treating or controlling endogenous hyperinsulinemic hypoglycemia using pasireotide or a pharmaceutically acceptable salt thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the control of hypoglycemia.
-
Citations
14 Claims
- 1. A method of treating or controlling endogenous hyperinsulinemic hypoglycemia using pasireotide or a pharmaceutically acceptable salt thereof.
- 9. A method of treating or controlling endogenous hyperinsulinemic hypoglycemia in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of pasireotide a pharmaceutically acceptable salt thereof.
-
13. A pharmaceutical composition for treatment of endogenous hyperinsulinemic hypoglycemia, comprising pasireotide or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable diluents or carriers.
-
14. A commercial package comprising pasireotide or a pharmaceutically acceptable salt thereof, together with instructions for use thereof in the treatment of endogenous hyperinsulinemic hypoglycemia.
Specification